Speech-Language Pathologists in Diboll, TX Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Natalie Dejesus Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4789 Buttermilk Rd, Diboll, TX 75941 Phone: 936-414-7313

Ms. Glenda Kelley, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 N Temple Dr, Diboll, TX 75941 Phone: 936-829-3100

News Archive

Diet rich in vegetables and fruit may decrease type 2 diabetes risk

A diet rich in vegetables and fruit may reduce the risk of type 2 diabetes, according to research published in the International Journal of Food Sciences and Nutrition.

FDA takes legal action against dietary supplement manufacturer in Pennsylvania

The FDA today took legal action against a dietary supplement maker and owner for substituting ingredients and products without noting the changes on the final product labels. The permanent injunction, filed on behalf of the FDA by the U.S. Department of Justice, would stop the defendants from making and distributing more than 400 products for being in violation of the Federal Food, Drug, and Cosmetic Act.

Study shows connection between genetic variants for ADHD and educational attainment

A study published in the February 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that five novel genetic variants associated with attention-deficit/hyperactivity disorder (ADHD) have been identified by exploiting genetic overlap between ADHD and educational attainment.

Toughbook Preferred Partners to sell Toughbook C1 product: DataSource Mobility

DataSource Mobility is pleased to announce that it is one of a select group of Toughbook Preferred Partners to sell the Toughbook C1—the newest healthcare specific product from Panasonic, the world leader in rugged mobile computers.

Senate, FDA reports increasing concerns about controversial diabetes drug

"Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market ... ," The New York Times reports. "The internal F.D.A. reports are part of a fierce debate within the agency over what to do about Avandia, manufactured by GlaxoSmithKline."

Read more Medical News

› Verified 2 days ago